N‐terminal methionine removal and methionine metabolism in Saccharomyces cerevisiae

Methionine aminopeptidase (MetAP) catalyzes removal of the initiator methionine from nascent polypeptides. In eukaryotes, there are two forms of MetAP, type 1 and type 2, whose combined activities are essential, but whose relative intracellular roles are unclear. Methionine metabolism is an important aspect of cellular physiology, involved in oxidative stress, methylation, and cell cycle. Due to the potential of MetAP activity to provide a methionine salvage pathway, we evaluated the relationship between methionine metabolism and MetAP activity in Saccharomyces cerevisiae. We provide the first demonstration that yeast MetAP1 plays a significant role in methionine metabolism, namely, preventing premature activation of MET genes through MetAP function in methionine salvage. Interestingly, in cells lacking MetAP1, excess methionine dramatically inhibits cell growth. Growth inhibition is independent of the ability of methionine to repress MET genes and does not result from inhibition of synthesis of another metabolite, rather it results from product inhibition of MetAP2. Inhibition by methionine is selective for MetAP2 over MetAP1. These results provide an explanation for the previously observed dominance of MetAP1 in terms of N‐terminal processing and cell growth in yeast. Additionally, differential regulation of the two isoforms may be indicative of different intracellular roles for the two enzymes. J. Cell. Biochem. 89: 964–974, 2003. © 2003 Wiley‐Liss, Inc.

[1]  Joseph A. Vetro,et al.  The specificity in vivo of two distinct methionine aminopeptidases in Saccharomyces cerevisiae. , 2002, Archives of biochemistry and biophysics.

[2]  K. Murata,et al.  Transformation of intact yeast cells treated with alkali cations. , 1984, Journal of bacteriology.

[3]  T. Podor,et al.  Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. , 1999, Blood.

[4]  M. Tyers,et al.  Dual regulation of the met4 transcription factor by ubiquitin-dependent degradation and inhibition of promoter recruitment. , 2002, Molecular cell.

[5]  K. Sudo,et al.  Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). , 1994, Anticancer research.

[6]  M. Tyers,et al.  SCF(Met30)-mediated control of the transcriptional activator Met4 is required for the G(1)-S transition. , 2000, The EMBO journal.

[7]  F Sherman,et al.  The specificities of yeast methionine aminopeptidase and acetylation of amino-terminal methionine in vivo. Processing of altered iso-1-cytochromes c created by oligonucleotide transformation. , 1990, The Journal of biological chemistry.

[8]  P. Wingfield,et al.  N-terminal methionine-specific peptidase in Salmonella typhimurium. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Bornmann,et al.  The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Vane,et al.  The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R A Bradshaw,et al.  Specificity of cotranslational amino-terminal processing of proteins in yeast. , 1987, Biochemistry.

[12]  K. Biemann,et al.  Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. , 1997, Chemistry & biology.

[13]  X Li,et al.  Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  I. Graham.  Homocysteine in Health and Disease , 1999, Annals of Internal Medicine.

[15]  Gene sam1 encoding adenosylmethionine synthetase: effects of its expression in the fission yeast Schizosaccharomyces pombe , 2000, Yeast.

[16]  S. Reed,et al.  Regulation of Transcription by Ubiquitination without Proteolysis Cdc34/SCFMet30-Mediated Inactivation of the Transcription Factor Met4 , 2000, Cell.

[17]  M. Tyers,et al.  SCFMet30‐mediated control of the transcriptional activator Met4 is required for the G1–S transition , 2000 .

[18]  A. Strauss.  Allelism of methionine-sensitive mutants of Schizosaccharomyces pombe to loci involved in adenine biosynthesis. , 1979, Genetical research.

[19]  S. Chang,et al.  Methionine aminopeptidase gene of Escherichia coli is essential for cell growth , 1989, Journal of bacteriology.

[20]  M. Tyers,et al.  Feedback‐regulated degradation of the transcriptional activator Met4 is triggered by the SCFMet30 complex , 2000, The EMBO journal.

[21]  Y. Chang,et al.  Evidence that the human homologue of a rat initiation factor-2 associated protein (p67) is a methionine aminopeptidase. , 1996, Biochemical and biophysical research communications.

[22]  Y. Chang,et al.  A dominant negative mutation in Saccharomyces cerevisiae methionine aminopeptidase-1 affects catalysis and interferes with the function of methionine aminopeptidase-2. , 1997, Archives of biochemistry and biophysics.

[23]  P. Meuris.  Studies of mutants inhibited by their own metabolites in Saccharomyces cerevisiae. II. Genetic and enzymatic analysis of three classes of mutants. , 1969, Genetics.

[24]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[25]  E. Stadtman,et al.  The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Goldman,et al.  Methionine-mediated lethality in yeast cells at elevated temperature , 1993, Journal of bacteriology.

[27]  D. Ingber,et al.  Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). , 1994, British Journal of Cancer.

[28]  D. Chakrabarti,et al.  Cloning and characterization of complementary DNA encoding the eukaryotic initiation factor 2-associated 67-kDa protein (p67). , 1993, The Journal of biological chemistry.

[29]  Y. Chang,et al.  Molecular cloning of a human complementary DNA encoding an initiation factor 2-associated protein (p67). , 1995, Biochimica et biophysica acta.

[30]  Joseph A. Vetro,et al.  Yeast methionine aminopeptidase type 1 is ribosome‐associated and requires its N‐terminal zinc finger domain for normal function in vivo * , 2002, Journal of cellular biochemistry.

[31]  Janina Maier,et al.  Guide to yeast genetics and molecular biology. , 1991, Methods in enzymology.

[32]  Y. Shibano,et al.  Single point mutations in Met4p impair the transcriptional repression of MET genes in Saccharomyces cerevisiae , 1996, FEBS letters.

[33]  R A Bradshaw,et al.  Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Smith,et al.  Molecular cloning, sequencing, deletion, and overexpression of a methionine aminopeptidase gene from Saccharomyces cerevisiae. , 1992, The Journal of biological chemistry.

[35]  K. Myambo,et al.  Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure , 1987, Journal of bacteriology.

[36]  K. Biemann,et al.  Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. , 1999, Chemistry & biology.